pubmed-article:12079940 | rdf:type | pubmed:Citation | lld:pubmed |
pubmed-article:12079940 | lifeskim:mentions | umls-concept:C0033325 | lld:lifeskim |
pubmed-article:12079940 | lifeskim:mentions | umls-concept:C0040100 | lld:lifeskim |
pubmed-article:12079940 | lifeskim:mentions | umls-concept:C0034902 | lld:lifeskim |
pubmed-article:12079940 | lifeskim:mentions | umls-concept:C0332281 | lld:lifeskim |
pubmed-article:12079940 | lifeskim:mentions | umls-concept:C0205210 | lld:lifeskim |
pubmed-article:12079940 | lifeskim:mentions | umls-concept:C2348519 | lld:lifeskim |
pubmed-article:12079940 | pubmed:issue | 2 | lld:pubmed |
pubmed-article:12079940 | pubmed:dateCreated | 2002-6-24 | lld:pubmed |
pubmed-article:12079940 | pubmed:abstractText | As information on the clinical features and prognosis of thymoma complicated by pure red-cell aplasia is limited, follow-up data on thymoma patients who had a thymectomy between 1954 and 1999 were analyzed retrospectively. Six of 166 cases were complicated by pure red-cell aplasia. In 3 of these, the pure red-cell aplasia appeared after surgical intervention. Remission was observed in 2 patients who underwent extended thymectomy. The other 4 patients subsequently died from pure red-cell aplasia. The outcome in patients with pure red-cell aplasia was poorer than that in the entire group of patients with thymoma and in those with thymoma complicated by myasthenia gravis. The possible onset of pure red-cell aplasia after thymectomy should be kept in mind during follow-up. | lld:pubmed |
pubmed-article:12079940 | pubmed:language | eng | lld:pubmed |
pubmed-article:12079940 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:12079940 | pubmed:citationSubset | IM | lld:pubmed |
pubmed-article:12079940 | pubmed:status | MEDLINE | lld:pubmed |
pubmed-article:12079940 | pubmed:month | Jun | lld:pubmed |
pubmed-article:12079940 | pubmed:issn | 0218-4923 | lld:pubmed |
pubmed-article:12079940 | pubmed:author | pubmed-author:FukayamaMasas... | lld:pubmed |
pubmed-article:12079940 | pubmed:author | pubmed-author:MurakawaTomoh... | lld:pubmed |
pubmed-article:12079940 | pubmed:author | pubmed-author:NakajimaJunJ | lld:pubmed |
pubmed-article:12079940 | pubmed:author | pubmed-author:TakamotoShini... | lld:pubmed |
pubmed-article:12079940 | pubmed:author | pubmed-author:TanakaMakotoM | lld:pubmed |
pubmed-article:12079940 | pubmed:author | pubmed-author:SatoHajimeH | lld:pubmed |
pubmed-article:12079940 | pubmed:issnType | Print | lld:pubmed |
pubmed-article:12079940 | pubmed:volume | 10 | lld:pubmed |
pubmed-article:12079940 | pubmed:owner | NLM | lld:pubmed |
pubmed-article:12079940 | pubmed:authorsComplete | Y | lld:pubmed |
pubmed-article:12079940 | pubmed:pagination | 150-4 | lld:pubmed |
pubmed-article:12079940 | pubmed:dateRevised | 2004-11-17 | lld:pubmed |
pubmed-article:12079940 | pubmed:meshHeading | pubmed-meshheading:12079940... | lld:pubmed |
pubmed-article:12079940 | pubmed:meshHeading | pubmed-meshheading:12079940... | lld:pubmed |
pubmed-article:12079940 | pubmed:meshHeading | pubmed-meshheading:12079940... | lld:pubmed |
pubmed-article:12079940 | pubmed:meshHeading | pubmed-meshheading:12079940... | lld:pubmed |
pubmed-article:12079940 | pubmed:meshHeading | pubmed-meshheading:12079940... | lld:pubmed |
pubmed-article:12079940 | pubmed:meshHeading | pubmed-meshheading:12079940... | lld:pubmed |
pubmed-article:12079940 | pubmed:meshHeading | pubmed-meshheading:12079940... | lld:pubmed |
pubmed-article:12079940 | pubmed:meshHeading | pubmed-meshheading:12079940... | lld:pubmed |
pubmed-article:12079940 | pubmed:meshHeading | pubmed-meshheading:12079940... | lld:pubmed |
pubmed-article:12079940 | pubmed:meshHeading | pubmed-meshheading:12079940... | lld:pubmed |
pubmed-article:12079940 | pubmed:meshHeading | pubmed-meshheading:12079940... | lld:pubmed |
pubmed-article:12079940 | pubmed:meshHeading | pubmed-meshheading:12079940... | lld:pubmed |
pubmed-article:12079940 | pubmed:meshHeading | pubmed-meshheading:12079940... | lld:pubmed |
pubmed-article:12079940 | pubmed:meshHeading | pubmed-meshheading:12079940... | lld:pubmed |
pubmed-article:12079940 | pubmed:meshHeading | pubmed-meshheading:12079940... | lld:pubmed |
pubmed-article:12079940 | pubmed:meshHeading | pubmed-meshheading:12079940... | lld:pubmed |
pubmed-article:12079940 | pubmed:meshHeading | pubmed-meshheading:12079940... | lld:pubmed |
pubmed-article:12079940 | pubmed:year | 2002 | lld:pubmed |
pubmed-article:12079940 | pubmed:articleTitle | Thymoma associated with pure red-cell aplasia: clinical features and prognosis. | lld:pubmed |
pubmed-article:12079940 | pubmed:affiliation | Department of Cardiothoracic Surgery, Faculty of Medicine, University of Tokyo, Tokyo, Japan. murakawa-tky@umin.ac.jp | lld:pubmed |
pubmed-article:12079940 | pubmed:publicationType | Journal Article | lld:pubmed |